U.S. Markets open in 39 hrs, 3 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 4.84 03:59 PM EDT | |
|---|---|---|
| Day High | 5.15 09:30 AM EDT |
|
| Range | 0.31 |
| Volume | 72,539 | |
|---|---|---|
| 30-Day Avg Vol | 197,000 |
|
| Difference | -63.18% |
| Market Cap | 122.40 M | |
|---|---|---|
| Mkt Cap Chg | -11.10 M |
| Shares Out | 25.23 M | |
|---|---|---|
| % Shrs Traded | 0.29% | |
| 1yr EPS Est | -2.18 |
| 52-Wk Low | 1.15 3/9/09 | |
|---|---|---|
| 52-Wk High | 8.90 8/19/08 |
|
| Range | 7.75 |
| Prev Close | 5.29 7/1/09 | |
|---|---|---|
| Today's Open | 5.15 | |
| Change | -2.65% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 1.03 M |
| Revenue (LFY) | 474,559 | |
|---|---|---|
| Earnings (LFY) | -81.25 M | |
| Earnings (MRQ) | -15.26 M | |
| Next Earn Est | -0.62 | |
| Next Earnings | 08/10/2009 |
|
| EPS (TTM) | -3.07 | |
| 1yr EPS Growth | 28.99% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -2.00 | |
| PEG Ratio | — | |
| Return on Equity | — | |
| Beta | — |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Broken hearts are hard to mend, but Molecular Insight Pharmaceuticals (MIP) is working to change that. The development-stage company is focused on making molecular imaging and radiotherapeutic products ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.62 8/10/09 | — — |
—
—
|
| Last Quarter | -0.62 3/31/09 | -0.61 3/31/09 |
0.01
Beat
|
| 2 Quarters Ago | -0.903 12/31/08 | -0.63 12/31/08 |
0.273
Beat
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 211,859.00 | 474,559.00 |
| Gross Profit | -51,535.00 | -428,034.00 |
| Operating Income | -10.24 M | -61.92 M |
| Net Income | -15.26 M | -81.25 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts